Pharmacology, Toxicology and Pharmaceutical Science
Receptor
100%
Agonist
28%
Bradykinin
26%
Arachidonic Acid
21%
Serotonin
19%
Ligand
18%
Antagonist
18%
Opiate Receptor
15%
Rat
13%
Heteromer
13%
Drug
13%
3,4 Dichloro N Methyl N [2 (1 Pyrrolidinyl)cyclohexyl]benzeneacetamide
12%
Protein Kinase C
12%
Desensitization
12%
Adenylate Cyclase
11%
Calcium
10%
Inverse Agonist
9%
Inositol Phosphate
9%
Enkephalin
9%
Phospholipase A2
8%
Opiate
8%
Cyclic AMP
8%
Functional Selectivity
7%
Pain
7%
Absence
7%
Retina S Antigen
7%
Naloxone
7%
Serotonin 2C Receptor
6%
Thermal Allodynia
6%
Chinese Hamster
6%
Norbinaltorphimine
6%
Phospholipase C
5%
Receptor Subtype
5%
Somatomedin C
5%
Mitogen Activated Protein Kinase 3
5%
Dopamine
5%
Phosphotransferase
5%
Proteinase Activated Receptor 2
5%
Delta Opiate Receptor
5%
Forskolin
5%
Insulin
5%
G Protein Coupled Receptor
5%
Neuroscience
Eicosanoid Receptor
66%
Bradykinin
39%
Agonist
32%
Sensory Neuron
26%
δ -Opioid Receptor
20%
5-HT2C Receptor
20%
In Vivo
20%
Arachidonic Acid
19%
Neuron
16%
Serotonin
12%
Opioid
12%
Protein Kinase C
10%
Enkephalin
10%
Ligand
10%
In Vitro
10%
Inverse Agonist
9%
Receptor Agonists
9%
Kappa Opiate Receptor
9%
Phospholipase C
9%
Κ-opioid receptor
9%
Nociceptor
9%
Inositol Phosphate
9%
Cell Signaling
8%
Trigeminal Ganglion
8%
Allodynia
7%
Kinase
7%
Norbinaltorphimine
7%
Amino Terminal Sequence
6%
Prostaglandin E2
6%
Extracellular Signal-Regulated Kinases
6%
Adenylyl Cyclase
6%
Receptor Subtype
6%
Brain
6%
Dopamine Release
5%
Dopamine
5%
Phospholipase A2
5%
5-HT2A Receptor
5%
Functional Selectivity
5%
Medicine and Dentistry
Receptor
67%
Agonist
23%
Ligand
12%
Chemotherapeutic Agent
10%
Drug
10%
Neuron
9%
Cells
9%
Selectivity
9%
Inverse Agonist
8%
Brain
8%
Receptor Subtype
8%
Bradykinin
7%
Therapeutic Procedure
7%
Inositol Phosphate
7%
Inverse Agonism
7%
Signal Transduction
7%
κ-Opioid Receptor
6%
In Vitro
6%
Pain
6%
Regulatory Mechanism
6%
Serotonin
6%
Ganglion
5%
Combination Therapy
5%
Nociceptor
5%
